A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

Ling,Stephanie F.; Yap,Chuan Fu; Nair,Nisha; Bluett,James; Morgan,Ann W.; Isaacs,John D.; Wilson,Anthony G.; Hyrich,Kimme L.; Barton,Anne; Plant,Darren

A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

All Authors

Ling,Stephanie F.

Yap,Chuan Fu

Nair,Nisha

Bluett,James

Morgan,Ann W.

Isaacs,John D.

Wilson,Anthony G.

Hyrich,Kimme L.

Barton,Anne

Plant,Darren

LTHT Author

Morgan, Ann-Wendy

LTHT Department

Rheumatology
NIHR Leeds Biomedical Research Centre

Publication Date

2024

Item Type

Article

Abstract

Objectives Biologic DMARDs (bDMARDs) are widely used in patients with RA, but response to bDMARDs is heterogeneous. The objective of this work was to identify pretreatment proteomic biomarkers associated with RA clinical outcome measures in patients starting bDMARDs. Methods Sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) was used to generate spectral maps of sera from patients with RA before and after 3?months of treatment with the bDMARD etanercept. Protein levels were regressed against RA clinical outcome measures, i.e. 28-joint DAS (DAS28) and its subcomponents and DAS28 <2.6 (i.e. remission). The proteins with the strongest evidence for association were analysed in an independent, replication dataset. Finally, subnetwork analysis was carried out using the Disease Module Detection algorithm and biological plausibility of identified proteins was assessed by enrichment analysis. Results A total of 180 patients with RA were included in the discovery dataset and 58 in the validation dataset from a UK-based prospective multicentre study. Ten individual proteins were found to be significantly associated with RA clinical outcome measures. The association of T-complex protein 1 subunit ? with DAS28 remission was replicated in an independent cohort. Subnetwork analysis of the 10 proteins from the regression analysis identified the ontological theme, with the strongest associations being with acute phase and acute inflammatory responses. Conclusion This longitudinal study of 180 patients with RA commencing etanercept has identified several putative protein biomarkers of treatment response to this drug, one of which was replicated in an independent cohort.